PRESCRIPTION MEDICATION

Motion Text

That this House believes that consumers have a right to expect full and impartial information about the potential risks and side-effects of prescription medication; further believes that this requires a robust regulatory framework to ensure that information is not only publicly available but also acted upon promptly; and, in the light of continuing consumer disquiet about Seroxat and similar concerns about other medicines, calls for an urgent, full, independent and open review of the UK drug regulatory system.